Lumexa Imaging (NASDAQ:LMRI) Reaches New 52-Week Low – Here’s Why

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) shares reached a new 52-week low on Thursday . The stock traded as low as $7.14 and last traded at $7.6350, with a volume of 292131 shares. The stock had previously closed at $8.05.

Analyst Ratings Changes

Several research firms have recently weighed in on LMRI. Barclays dropped their target price on shares of Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Raymond James Financial raised shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 target price for the company in a research report on Monday, February 9th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to data from MarketBeat.com, Lumexa Imaging presently has an average rating of “Strong Buy” and an average price target of $19.00.

Lumexa Imaging Stock Performance

The firm’s 50-day moving average price is $10.67.

Institutional Investors Weigh In On Lumexa Imaging

Institutional investors have recently modified their holdings of the business. State of Wyoming bought a new stake in shares of Lumexa Imaging during the 1st quarter valued at about $91,000. PNC Financial Services Group Inc. bought a new stake in shares of Lumexa Imaging during the 1st quarter valued at about $63,000. Bank of New York Mellon Corp bought a new stake in shares of Lumexa Imaging during the 1st quarter valued at about $479,000. Emerald Mutual Fund Advisers Trust boosted its stake in Lumexa Imaging by 11.0% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 653,342 shares of the company’s stock valued at $5,619,000 after purchasing an additional 64,677 shares during the period. Finally, Principal Financial Group Inc. grew its position in Lumexa Imaging by 1.2% in the 1st quarter. Principal Financial Group Inc. now owns 664,136 shares of the company’s stock worth $5,712,000 after purchasing an additional 7,875 shares during the last quarter.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).